Presentation is loading. Please wait.

Presentation is loading. Please wait.

Number of days from insertion of intrauterine device or intrauterine system to first major event in patients receiving frequent or infrequent systematic.

Published byVeronika Irawan Modified over 6 years ago

Similar presentations

Presentation on theme: "Number of days from insertion of intrauterine device or intrauterine system to first major event in patients receiving frequent or infrequent systematic."— Presentation transcript:

1 Number of days from insertion of intrauterine device or intrauterine system to first major event in patients receiving frequent or infrequent systematic checks. Number of days from insertion of intrauterine device or intrauterine system to first major event in patients receiving frequent or infrequent systematic checks. Isabel B Draper et al. J Fam Plann Reprod Health Care 2012;38:15-18 Copyright © by the BMJ Publishing Group Ltd & the Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists. All rights reserved.

Download ppt "Number of days from insertion of intrauterine device or intrauterine system to first major event in patients receiving frequent or infrequent systematic."

Similar presentations

 Categorisation of direct and indirect admissions to the intensive care unit (ICU) from emergency departments (EDs), using source of admission.  Categorisation.

 Categorisation of direct and indirect admissions to the intensive care unit (ICU) from emergency departments (EDs), using source of admission.  Categorisation.
Neonatal chest radiograph taken on the patient's arrival at the neonatal intensive care unit, at 1 hour of life and high frequency oscillation ventilation.

Neonatal chest radiograph taken on the patient's arrival at the neonatal intensive care unit, at 1 hour of life and high frequency oscillation ventilation.
 Correlation between plasma total antioxidant capacity of plasma (TAC) and protein SH groups (SH) (A), total hydroperoxide concentration (TH) and TAC (B),

 Correlation between plasma total antioxidant capacity of plasma (TAC) and protein SH groups (SH) (A), total hydroperoxide concentration (TH) and TAC (B),
Box plot of subarachnoid space measurements at each gestational week of age. Box plot of subarachnoid space measurements at each gestational week of age.

Box plot of subarachnoid space measurements at each gestational week of age. Box plot of subarachnoid space measurements at each gestational week of age.
Box plot of head circumference measurements at each gestational week of age. Box plot of head circumference measurements at each gestational week of age.

Box plot of head circumference measurements at each gestational week of age. Box plot of head circumference measurements at each gestational week of age.
Pulse field gel electrophoresis: Lane 1 Lamda marker; lanes 2 to 5 K pneumoniae isolates from cases 3 to 6; lane 6 isolate from case 7; lane 7 ESBL negative.

Pulse field gel electrophoresis: Lane 1 Lamda marker; lanes 2 to 5 K pneumoniae isolates from cases 3 to 6; lane 6 isolate from case 7; lane 7 ESBL negative.
Flow chart of patients undergoing intra-caesarean insertion of postplacental intrauterine contraceptive device (PPIUD). Flow chart of patients undergoing.

Flow chart of patients undergoing intra-caesarean insertion of postplacental intrauterine contraceptive device (PPIUD). Flow chart of patients undergoing.
Plot of average differences in arterial blood pressure using the two methods in mm Hg against both methods for systolic blood pressure (A) and diastolic.

Plot of average differences in arterial blood pressure using the two methods in mm Hg against both methods for systolic blood pressure (A) and diastolic.
 Schematic representation of the two types of gastric volvulus: organoaxial volvulus occurs around the line A–A and mesenteroaxial volvulus occurs around.

 Schematic representation of the two types of gastric volvulus: organoaxial volvulus occurs around the line A–A and mesenteroaxial volvulus occurs around.
Pancreatic elastase (E1) levels in the two groups of newborn infants.

Pancreatic elastase (E1) levels in the two groups of newborn infants.
Chart 3: Working example of oxygen section for hospital prescription charts (two panels are required on the prescription chart because oxygen may change.

Chart 3: Working example of oxygen section for hospital prescription charts (two panels are required on the prescription chart because oxygen may change.
Examples of Mirena® Haptic ‘end effectors’

Examples of Mirena® Haptic ‘end effectors’
Box plot representation of serum cytokines levels (pg/ml) in group A (nasal continuous positive airway pressure (NCPAP)) and group B (bi-level NCPAP) at.

Box plot representation of serum cytokines levels (pg/ml) in group A (nasal continuous positive airway pressure (NCPAP)) and group B (bi-level NCPAP) at.
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
Preprocedure patient ranking of aspects of their care important for obtaining satisfaction with their colonoscopy experience (1=high, 15=low for importance)

Preprocedure patient ranking of aspects of their care important for obtaining satisfaction with their colonoscopy experience (1=high, 15=low for importance)
Effect of confidence interval reduction to demonstrate a true difference in means. Effect of confidence interval reduction to demonstrate a true difference.

Effect of confidence interval reduction to demonstrate a true difference in means. Effect of confidence interval reduction to demonstrate a true difference.
Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and.

Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and.
(A) Annual proportion of new users and (B) proportion of overall use of each product over the study period. (A) Annual proportion of new users and (B)

(A) Annual proportion of new users and (B) proportion of overall use of each product over the study period. (A) Annual proportion of new users and (B)
Subgroup analysis of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Subgroup analysis of the 17 trials comparing.

Subgroup analysis of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Subgroup analysis of the 17 trials comparing.
Funnel plot of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Funnel plot of the 17 trials comparing haloperidol.

Funnel plot of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Funnel plot of the 17 trials comparing haloperidol.

Similar presentations

Ads by Google